Discontinued — last reported Q1 '20
Other
AOCI - Cash Flow Hedge Reclassification (Next 12 Months)
Biogen AOCI - Cash Flow Hedge Reclassification (Next 12 Months) decreased by 81.9% to $16.40M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 22.4%, from $13.40M to $16.40M.
Analysis
StatementBalance Sheet Statement
SectionOther
CategoryProfitability
SignalContext dependent
VolatilityModerate
First reportedQ4 2018
Last reportedQ1 2020
How to read this metric
Provides visibility into future earnings volatility related to existing hedge contracts.
Detailed definition
This represents the portion of gains or losses on cash flow hedges currently held in Accumulated Other Comprehensive Inc...
Peer comparison
Standard disclosure for companies using hedge accounting under ASC 815.
Metric ID:
aoci_cash_flow_hedge_reclassification_12mHistorical Data
6 periods
| Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|
| Value | $1.90M | $38.50M | $13.40M | $111.10M | $90.80M | $16.40M |
| QoQ Change | — | >999% | -65.2% | +729.1% | -18.3% | -81.9% |
| YoY Change | — | — | — | >999% | +135.8% | +22.4% |
Range$1.90M – $111.10M
CAGR+460.9%
Avg YoY Growth>999%
Median YoY Growth+135.8%
Current Streak2 quarters decline
AOCI - Cash Flow Hedge Reclassification (Next 12 Months) at Other Companies
Frequently Asked Questions
- What is Biogen's aoci - cash flow hedge reclassification (next 12 months)?
- Biogen (BIIB) reported aoci - cash flow hedge reclassification (next 12 months) of $16.40M in Q1 2026.
- How has Biogen's aoci - cash flow hedge reclassification (next 12 months) changed year-over-year?
- Biogen's aoci - cash flow hedge reclassification (next 12 months) increased by 22.4% year-over-year, from $13.40M to $16.40M.
- What does aoci - cash flow hedge reclassification (next 12 months) mean?
- The amount of hedge gains or losses expected to hit the income statement over the next 12 months.